UBS AM’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.11M | Buy |
|
|||||
|
2025
Q1 | $1.38M | Buy |
|
|||||
|
2024
Q4 | $711K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $655K | Buy |
|
|||||
|
2023
Q4 | $839K | Hold |
|
|||||
|
2023
Q3 | $934K | Buy |
|
|||||
|
2023
Q2 | $1.09M | Hold |
|
|||||
|
2023
Q1 | $1.09M | Buy |
|
|||||
|
2022
Q4 | $857K | Buy |
|
|||||
|
2022
Q3 | $781K | Buy |
|
|||||
|
2022
Q2 | $861K | Sell |
|
|||||
|
2022
Q1 | $2.38M | Buy |
|
|||||
|
2021
Q4 | $4.36M | Buy |
|
|||||
|
2021
Q3 | $5.13M | Buy |
|
|||||
|
2021
Q2 | $6.06M | Sell |
|
|||||
|
2021
Q1 | $11.2M | Buy |
|
|||||
|
2020
Q4 | $16.4M | Buy |
|
|||||
|
2020
Q3 | $11.9M | Buy |
|
|||||
|
2020
Q2 | $11.4M | Buy |
|
|||||
|
2020
Q1 | $1.78M | Buy |
|
|||||
|
2019
Q4 | $1.53M | Sell |
|
|||||
|
2019
Q3 | $1.59M | Buy |
|
|||||
|
2019
Q2 | $2.42M | Buy |
|